These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2412057)

  • 1. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle.
    Myers JH; Mecca TE; Webb RC
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S44-8. PubMed ID: 2412057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and vascular reactivity.
    Van Nueten JM; Janssens WJ; Vanhoutte PM
    Pharmacol Res Commun; 1985 Jul; 17(7):585-608. PubMed ID: 2931729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and the vascular wall.
    Vanhoutte PM
    Int J Cardiol; 1987 Feb; 14(2):189-203. PubMed ID: 3818135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of potent and selective S2-serotonergic antagonists.
    Janssen PA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S2-11. PubMed ID: 2412048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors.
    Peroutka SJ; Noguchi M; Tolner DJ; Allen GS
    Brain Res; 1983 Jan; 259(2):327-30. PubMed ID: 6824943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model.
    Miyata K; Shimokawa H; Higo T; Yamawaki T; Katsumata N; Kandabashi T; Tanaka E; Takamura Y; Yogo K; Egashira K; Takeshita A
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):294-301. PubMed ID: 10672864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and the blood vessel wall.
    Van Nueten JM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S49-51. PubMed ID: 2412058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.
    Peroutka SJ
    Biochem Pharmacol; 1984 Aug; 33(15):2349-53. PubMed ID: 6380502
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
    Sumner MJ; Feniuk W; McCormick JD; Humphrey PP
    Br J Pharmacol; 1992 Mar; 105(3):603-8. PubMed ID: 1320980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of serotonin.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S8-11. PubMed ID: 2446079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and arterial vessels.
    Vanhoutte PM; Cohen RA; Van Nueten JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S421-8. PubMed ID: 6206351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic receptor subtypes and vascular reactivity.
    Van Nueten JM; Leysen JE; de Clerck F; Vanhoutte PM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S564-74. PubMed ID: 6210424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
    Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
    Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS; Vanhoutte PM
    Drugs; 1986 Feb; 31(2):149-63. PubMed ID: 3512233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
    Terrón JA
    Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.